Research ArticleCANCER

Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy

See allHide authors and affiliations

Science Advances  03 Jul 2020:
Vol. 6, no. 27, eaba8564
DOI: 10.1126/sciadv.aba8564

Article Information

vol. 6 no. 27

PubMed: 
Online ISSN: 
History: 
  • Received for publication January 10, 2020
  • Accepted for publication May 20, 2020
  • .

Author Information

  1. Kin Man Au1,2,
  2. Steven I. Park3,4 and
  3. Andrew Z. Wang1,2,*
  1. 1Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  2. 2Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  3. 3Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  4. 4Levine Cancer Institute, Atrium Health, Division of Hematology and Oncology, 1021 Morehead Medical Dr, Suite 20121, Charlotte, NC 28025, USA.
  1. *Corresponding author. Email: zawang{at}med.unc.edu

Altmetric

Article usage

Article usage: July 2020 to May 2021

AbstractFullPdf
Jul 20202823163828
Aug 20209575178
Sep 20207414309
Oct 202020366165
Nov 20209242112
Dec 202013403197
Jan 202119399173
Feb 2021428197
Mar 202111340126
Apr 20214477117
May 2021111841

Stay Connected to Science Advances

Navigate This Article